Patent details
EP3840726 Title: LIPASE DEGRADATION RESISTANT SURFACTANTS FOR USE IN LARGE MOLECULE THERAPEUTIC FORMULATIONS
Basic Information
- Publication number:
- EP3840726
- PCT Application Number:
- IB2019057079
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP198520090
- PCT Publication Number:
- WO2020039384
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- LIPASE DEGRADATION RESISTANT SURFACTANTS FOR USE IN LARGE MOLECULE THERAPEUTIC FORMULATIONS
- French Title of Invention:
- TENSIOACTIFS RÉSISTANT À LA DÉGRADATION DE LIPASE DESTINÉS À ÊTRE UTILISÉS DANS DES FORMULATIONS THÉRAPEUTIQUES À GRANDE MOLÉCULE
- German Title of Invention:
- LIPASE-ABBAUBESTÄNDIGE TENSIDE ZUR VERWENDUNG IN GROSSMOLEKULAREN THERAPEUTISCHEN FORMULIERUNGEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 25/04/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 03/05/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 03/04/2024
- Unitary Effect Registration Date:
- 03/05/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 22/08/2019
- Grant date:
- 03/04/2024
- EP Publication Date:
- 30/06/2021
- PCT Publication Date:
- 27/02/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/04/2024
- EP B1 Publication Date:
- 03/04/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 22/08/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/03/2024
- Name:
- Janssen Biotech, Inc.
- Address:
- 800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)
Inventor
1
- Name:
- STAHL, Patrick
- Address:
- United States (US)
2
- Name:
- LABRENZ, Steven
- Address:
- United States (US)
Priority
- Priority Number:
- 201862721884 P
- Priority Date:
- 23/08/2018
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/08; A61K 39/395; A61K 39/44; A61K 47/10; A61K 47/34; A61K 31/25; A61K 38/46;
Publication
European Patent Bulletin
1
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Grant (B1)
2
- Issue number:
- 202418
- Publication date:
- 01/05/2024
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
3
- Issue number:
- 202422
- Publication date:
- 29/05/2024
- Description:
- Unitary Effect Request Receipt
4
- Issue number:
- 202423
- Publication date:
- 05/06/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|